Doseology Sciences Inc.

OTCQB:DOSEF USA Biotechnology
Market Cap
$761.10K
Market Cap Rank
#48298 Global
#14853 in USA
Share Price
$0.10
Change (1 day)
+0.00%
52-Week Range
$0.10 - $0.10
All Time High
$1.00
About

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distribut… Read more

Doseology Sciences Inc. - Asset Resilience Ratio

Latest as of March 2023: 39.48%

Doseology Sciences Inc. (DOSEF) has an Asset Resilience Ratio of 39.48% as of March 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$1.14 Million
Cash + Short-term Investments
Total Assets
$2.89 Million
All company assets
Resilience Assessment
Very High
Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Doseology Sciences Inc.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Doseology Sciences Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $1.14 Million 39.48%
Total Liquid Assets $1.14 Million 39.48%

Asset Resilience Insights

  • Very High Liquidity: Doseology Sciences Inc. maintains exceptional liquid asset reserves at 39.48% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Doseology Sciences Inc. Industry Peers by Asset Resilience Ratio

Compare Doseology Sciences Inc.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
MedPacto Inc
KQ:235980
Biotechnology 49.82%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%
Hualan Biological EngineeringInc
SHE:002007
Biotechnology 14.68%
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
Biotechnology 4.35%

Annual Asset Resilience Ratio for Doseology Sciences Inc. (None–None)

The table below shows the annual Asset Resilience Ratio data for Doseology Sciences Inc..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
No yearly data available.
pp = percentage points